Antibacterial Resistance and Infection Control in ICU
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotic Therapy in Infectious Diseases".
Deadline for manuscript submissions: 20 October 2024 | Viewed by 12788
Special Issue Editors
Interests: sepsis; antimicrobial resistance and infection control; antimicrobial stewardship; therapeutic drug monitoring; PK/PD of antimicrobial agents; critical care medicine
Special Issue Information
Dear Colleagues,
The increasing pressure of antimicrobial resistance (AMR) in healthcare-associated infections (HAIs), especially in critically ill patients, is one of the main challenging emergency issues to solve worldwide. Infection and prevention control programs promoted by the World Health Organization (WHO) are aimed to reduce the incidence of HAIs by introducing specific protocols. However, most of the countries worldwide have not yet implemented these protocols in clinical practice.
The aim of this Special Issue is to examine all the possible strategies that might contribute to reducing antimicrobial resistance and allow the control of HAIs. You can give your contribution with an original article, a systematic review or meta-analysis, and review articles.
The main topics are as follows:
- Epidemiology of healthcare-associated infections (HAIs).
- Infection control in the ICU.
- How can microbiology have an impact on antimicrobial resistance control?
- IVAC/VAP in the ICU—from prevention to treatment.
- Could we reach “zero” CR-BSI?
- SSI: where we are—do the bundles work?
- Management of intra-abdominal infection.
- Empirical treatment or semi-targeted therapy—what is the dilemma?
- Role of PK/PD in improving AMR control. How to optimize antibiotic therapy in critically ill patients.
- De-escalation—is it feasible in critically ill patients?
- When to stop antimicrobial therapy.
- Biomarkers and AMR.
Dr. Daniela C. Pasero
Dr. Francesco Forfori
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.